All of the following are paraneoplastic syndromes of bronchogenic carcinoma except:
## **Core Concept**
Paraneoplastic syndromes are conditions caused by the immune response to a neoplasm, or by substances produced by tumor cells. Bronchogenic carcinoma, also known as lung cancer, can cause various paraneoplastic syndromes due to its production of ectopic hormones, antibodies, or other factors.
## **Why the Correct Answer is Right**
Option is associated with myasthenia gravis, which is more commonly linked to thymoma rather than being a direct paraneoplastic syndrome of bronchogenic carcinoma. Myasthenia gravis is an autoimmune disease characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by an antibody-mediated process targeting the acetylcholine receptor at the neuromuscular junction. While various cancers can be associated with myasthenia gravis, the primary and most well-known association is with thymic tumors.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Cushing's syndrome can be a paraneoplastic syndrome of bronchogenic carcinoma, specifically small cell lung cancer (SCLC), due to the ectopic production of adrenocorticotropic hormone (ACTH) or ACTH-releasing factors by the tumor.
- **Option B:** Hypercalcemia is a common paraneoplastic syndrome in lung cancer, particularly SCLC and squamous cell carcinoma, often due to the production of parathyroid hormone-related protein (PTHrP) or other factors that lead to increased calcium levels.
- **Option D:** Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is another well-recognized paraneoplastic syndrome associated with SCLC, caused by the ectopic production of antidiuretic hormone (ADH) or vasopressin.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that small cell lung cancer (SCLC) is more frequently associated with paraneoplastic syndromes compared to non-small cell lung cancer (NSCLC). This is because SCLC has a higher propensity to produce ectopic hormones.
## **Correct Answer: .**